Sonnet BioTherapeutics Holdings Inc (NASDAQ:SONN) Climbs 91.46% In 2024; Are Investors Attracted By Its $0.66 Price?
In last trading session, Sonnet BioTherapeutics Holdings Inc (NASDAQ:SONN) saw 0.74 million shares changing hands with its beta currently measuring 0.49. Company’s recent per share